Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.06% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Mar 31, 2026
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-26-003819General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-25.62% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-9.13% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
162.80% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
26.96% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-17.25% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.48%
- Current
- 0.06%
- Delta
- -0.42%
- Previous
- -14.68%
- Current
- -25.62%
- Delta
- -10.93%
- Previous
- 4.11%
- Current
- -9.13%
- Delta
- -13.23%
- Previous
- 37.11%
- Current
- 162.80%
- Delta
- 125.69%
- Previous
- 33.76%
- Current
- 26.96%
- Delta
- -6.79%
- Previous
- -17.15%
- Current
- -17.25%
- Delta
- -0.10%
- Previous
- 1.66%
- Current
- 0.39%
- Delta
- -1.27%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Analogous To · SBFM state analogue 4 →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CAPEX_INTENSITY_DECREASED →Transitioned To · SBFM CASH_GENERATION_DECREASED →Transitioned To · SBFM GROWTH_DECREASED →Transitioned To · SBFM INVENTORY_PRESSURE_INCREASED →Transitioned To · SBFM MARGIN_DECREASED →Transitioned To · SBFM PROFITABILITY_DECREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.